Tag: Prescription Drugs
Bupropion-Naltrexone Bests Placebo in Methamphetamine Use Disorder
Response was low but higher with naltrexone-bupropion than placebo during 12-week, two-stage trial
Stopping RAS Inhibitors May Worsen Outcomes in CKD
Stopping therapy tied to lower risk for dialysis, but higher risk for cardiovascular events and death
Inhaled Treprostinil Beneficial in Pulmonary Hypertension
Exercise capacity improved, clinical worsening reduced for patients with pulmonary HTN due to interstitial lung disease
Women Must Get Abortion Pill in Person: U.S. Supreme Court
Similar in-person rules for other medications have been suspended during the pandemic
Experimental Drug for Alzheimer Disease Shows Promise
After six to 12 months of treatment with the drug, patients no longer had amyloid protein plaques
Hydroxychloroquine Level Tied to Thrombosis Risk in Lupus
Rate of thrombotic events lower for patients with mean HCQ blood levels >1,068 versus <648 ng/mL
Sitagliptin Promising Addition for Preventing Acute GVHD
Low incidence of grade II to IV acute GVHD seen in patients undergoing myeloablative allogeneic hematopoietic stem cell transplantation
Drug Makers Raise Prices on 500 Prescription Drugs
AbbVie, Bristol Myers Squibb, GlaxoSmithKline, and Pfizer among companies raising their prices by a median of 4.6 percent
Euglycemic DKA ID’d in T2DM Patients With COVID-19
Five cases of euDKA identified in patients with type 2 diabetes using SGLT2 inhibitors who developed SARS-CoV-2 infection
Jaw Osteonecrosis Tied to Treatment for Bone Metastases
Cancer type, oral health, and frequency of dosing for zoledronic acid linked to risk for osteonecrosis of the jaw
